Skip to main content
Veterinary Medicines

Nekro Veyxym suspenzija za injiciranje

Authorised
  • Chymotrypsin
  • Trypsin
  • Papain

Product identification

Medicine name:
Nekro Veyxym suspenzija za injiciranje
Active substance:
  • Chymotrypsin
  • Trypsin
  • Papain
Target species:
  • Cattle
  • Pig
  • Sheep
  • Goat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Chymotrypsin
    1200.00
    FIP
    /
    1.00
    millilitre(s)
  • Trypsin
    120.00
    FIP
    /
    1.00
    millilitre(s)
  • Papain
    15.00
    FIP
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal, milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal, milk
        0
        day
    • Goat
      • Meat and offal, milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD03BA
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Available in:
  • Slovenia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • NP/V/0210/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 30/11/2021
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."